Patents by Inventor Timothy L. Kessler

Timothy L. Kessler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of inhibitors of gag synthesis for the treatment of corneal haze
    Patent number: 6399107
    Abstract: This invention relates to the compositions and methods for the treatment of corneal haze. The compositions and methods are particularly directed to the use of GAG synthesis inhibitors in the treatment of corneal haze.
    Type: Grant
    Filed: June 20, 2001
    Date of Patent: June 4, 2002
    Assignee: Alcon Laboratories, Inc.
    Inventors: Timothy L. Kessler, Jon C. Nixon, Karen C. David, Gustav Graff
  • Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
    Patent number: 6353022
    Abstract: Compositions containing one or more HETE derivative(s) and an effective concentration of ethanol and methods of use for treating dry eye are disclosed.
    Type: Grant
    Filed: October 23, 2000
    Date of Patent: March 5, 2002
    Assignee: Alcon Universal Ltd.
    Inventors: L. Wayne Schneider, Daniel A. Gamache, Lori K. Weimer, Timothy L. Kessler, Zhongyou Wei, Terri Pasquine, John M. Yanni, Haresh G. Bhagat
  • Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
    Patent number: 5545617
    Abstract: A method of treating patients suffering from aberrant conjunctival goblet cell mucous secretion associated with a disorder of or injury to the eye is disclosed. The method, which is based on the discovery that conjunctival goblet cell mucous secretion is under the control of the autonomic nervous system, includes administering to an affected eye of a patient a neural system stimulus or inhibitor for sensory, parasympathetic or sympathetic nervous system function. Also disclosed are a therapeutic composition and an article of manufacture including the therapeutic composition useful for carrying out the method of the invention.
    Type: Grant
    Filed: November 12, 1993
    Date of Patent: August 13, 1996
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: Darlene A. Dartt, Timothy L. Kessler